Diplomat Managing Rising Drug Costs to Support Patients

FLINT, Mich., Feb. 21, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications. Joel Saban, president of Diplomat, said the growing market for high-cost...